BIOMEDICAL OPTICS: International congress lays the groundwork for biophotonics roadmap

April 1, 2008
Scientists, academicians, and representatives of government and industry spent several days discussing the future of biomedical optics at the first International Congress on Biophotonics (ICOB; Feb. 3-7; Sacramento, CA).

Scientists, academicians, and representatives of government and industry spent several days discussing the future of biomedical optics at the first International Congress on Biophotonics (ICOB; Feb. 3-7; Sacramento, CA), sponsored by the NSF Center for Biophotonics Science & Technology (CBST; Davis, CA). Some 125 attendees from Ireland, Scotland, Denmark, Germany, Australia, Taiwan, China, Canada, and the United States heard and gave presentations on key application and technology segments and participated in a number of breakout sessions designed to begin building a strategic roadmap for the future of biophotonics research, technology development, and education.

Attendees learned about major achievements in three areas: advanced microimaging; probes, sensors, and assays; and clinical applications of biophotonics. In addition, they heard presentations about current and projected needs in cancer, infectious disease, cardiovascular disease, regenerative medicine, and neuroscience. Among the highlights:

Prof. Brian Wilson of the University of Toronto gave a plenary talk on the use of photodynamic therapy to treat infectious diseases, providing a “nonantibiotic” treatment approach to bacterial infections.

Prof. Stefan Hell of the Max-Planck Institute for Biophysical Chemistry (Göttingen, Germany) described how his stimulated emission depletion nonlinear microscopy techniques have opened the door to “nanoscopy.” Up to 80-frames/s, 20- to 30-nm-resolution fluorescence nanoscopy is now available, and Leica will soon offer nanoscopes for sale. This level of resolution enables the study of intra- and extra-subcellular organism dynamics without the need for labels.

Neurobiologist Yves de Koninck of Laval University (Quebec, Canada) described his work on studying neuronal function and structure. He challenged the microscopy community to develop high-spatio-temporal microscopy techniques that can achieve high resolution over large-scale lengths (microns to millimeters) and capture images in 1 ms or less.

A panel of representatives from NIH, NSF, AFOSR, DoD, and similar agencies in Canada and the EU discussed their interest in creating new funding initiatives for biophotonics R&D.

Worldwide support

According to Dennis Matthews, director of the CBST and cochair of the ICOB, a clear message to come out of the ICOB is the need to focus biophotonics on some major challenges in bioscience and medicine, he adds. In response to this need, a worldwide initiative, “Biophotonics for Life,” will likely be created as part of the group’s roadmapping efforts. According to Matthews, this initiative will focus resources on such medical challenges as noninvasive measurement of blood glucose, nonantibiotic treatment of infections, revolutionizing pathology by bringing lab diagnostics to the point-of-care, creating better methods of treating presbyopia, providing therapies for metastastic-level cancer, and bringing new methods to emergency medicine for rapid diagnosis and field-portable imaging.

Another important message from the ICOB was the need to develop funding initiatives that encourage large-scale international partnering on biophotonics. According to Matthews, international scientist exchange programs are readily available, but there will be new efforts to create the equivalent of international biophotonics Centers of Excellence or research partnerships. A continuous path for funding of the translation of technology from bench to bedside was also identified as one of the biggest barriers to creating new medical and bioscience devices and tools.

“Our technology readiness levels (TRL scale of 1 to 10, with 1 being ‘concept’ and 10 being ‘marketable device’) mostly fall victim to the ‘valley of death’ (TRL 3 to 7),” Matthews says. “There are many reasons for this, but mostly because there is no NIH-style government or private funding available for getting technology to the stage where it can be commercialized and doing so at entrepreneurial speed. The biophotonics community will now focus on developing initiatives to mitigate this substantial barrier to innovation.”

The ICOB highlighted BiophotonicsWorld.org, a web site recently launched by CBST and the Canadian Institute for Photonic Innovations to serve as a central resource for biophotonics tools, news, and information for researchers, students, teachers, and industry.

The next ICOB will be held in Canada in 2010.

About the Author

Kathy Kincade | Contributing Editor

Kathy Kincade is the founding editor of BioOptics World and a veteran reporter on optical technologies for biomedicine. She also served as the editor-in-chief of DrBicuspid.com, a web portal for dental professionals.

Sponsored Recommendations

Request a free Micro 3D Printed sample part

April 11, 2024
The best way to understand the part quality we can achieve is by seeing it first-hand. Request a free 3D printed high-precision sample part.

How to Tune Servo Systems: The Basics

April 10, 2024
Learn how to tune a servo system using frequency-based tools to meet system specifications by watching our webinar!

Motion Scan and Data Collection Methods for Electro-Optic System Testing

April 10, 2024
Learn how different scanning patterns and approaches can be used in measuring an electro-optic sensor performance, by reading our whitepaper here!

How Precision Motion Systems are Shaping the Future of Semiconductor Manufacturing

March 28, 2024
This article highlights the pivotal role precision motion systems play in supporting the latest semiconductor manufacturing trends.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!